Geraldine Labarchede-Buhagiar
Orsay, 91405, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients.
Journal: Scientific reports
Published: December 05, 2022
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels.
Journal: Cellular and molecular life sciences : CMLS
Published: May 02, 2022
Cytidine deaminase activity increases in the blood of breast cancer patients.
Journal: Scientific reports
Published: January 04, 2022
Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms.
Journal: Open biology
Published: May 14, 2020
Cytidine deaminase deficiency impairs sister chromatid disjunction by decreasing PARP-1 activity.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 03, 2017
A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival.
Journal: Nature communications
Published: January 04, 2017
Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 08, 2016
A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formation.
Journal: Journal of cell science
Published: February 14, 2016
Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA.
Journal: PLoS genetics
Published: January 27, 2015
Last Updated: 09/26/2026